{"id":"W4392954109","doi":"10.1080/10428194.2024.2328800","title":"Momelotinib vs. ruxolitinib in myelofibrosis patient subgroups by baseline hemoglobin levels in the SIMPLIFY-1 trial","year":2024,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"GlaxoSmithKline","keywords":"Ruxolitinib; Myelofibrosis; Anemia; Post-hoc analysis; Medicine; Janus kinase; Internal medicine; Hemoglobin; Randomized controlled trial; Janus kinase 2; Clinical trial; Gastroenterology; Receptor; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002061882,0.0008061251,0.001990411,0.0002581708,0.000194646,0.0008231068,0.0003463761,0.0005931259,0.002454316],"category_scores_gemma":[0.001851434,0.0002350457,0.002177696,0.0002130384,0.0003549253,0.0004978525,0.0003978793,0.001342252,0.0002112129],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003616825,"about_ca_system_score_gemma":0.0005824371,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002577045,"about_ca_topic_score_gemma":0.00145667,"domain_scores_codex":[0.9991817,0.0005070569,0.00005756907,0.00009102094,0.00006126449,0.0001015129],"domain_scores_gemma":[0.9993398,0.0002703982,0.0001881666,0.00005354264,0.00002844987,0.0001197465],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9692163,0.002188037,0.003257375,0.0004557119,0.002111774,0.00006441223,0.000062569,0.0008184526,0.003082656,0.0002613664,0.001217647,0.01726369],"study_design_scores_gemma":[0.8384764,0.1178938,0.02801965,0.0001472995,0.00472185,0.0001967737,0.000121805,0.003344851,0.002261278,0.00130374,0.003458997,0.00005362738],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9925374,0.003461726,0.0002658742,0.0003836233,0.0001281812,0.0006695252,0.0005737114,0.00003551917,0.001944416],"genre_scores_gemma":[0.9938679,0.001063401,0.0006567821,0.0006628009,0.0002291873,0.0007821096,0.001319575,0.000009872583,0.001408437],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002454316,"threshold_uncertainty_score":0.01090443,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01462902550181141,"score_gpt":0.2639739017926614,"score_spread":0.24934487629085,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}